Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Cadrenal Therapeutics, Inc. (CVKD) had Free Cash Flow of $-3.00M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.50M |
|
-- |
|
-- |
|
$2.51M |
|
$-2.51M |
|
$0.02M |
|
$-2.50M |
|
$-2.50M |
|
$-2.50M |
|
$-2.50M |
|
$-2.50M |
|
$-2.50M |
|
$-2.51M |
|
$-2.51M |
|
2.41M |
|
2.41M |
|
$-1.04 |
|
$-1.04 |
|
| Balance Sheet Financials | |
$2.86M |
|
$0.00M |
|
$0.01M |
|
$2.86M |
|
$1.06M |
|
-- |
|
-- |
|
$1.06M |
|
$1.80M |
|
$1.80M |
|
$1.80M |
|
2.51M |
|
| Cash Flow Statement Financials | |
$-3.00M |
|
$0.00M |
|
$1.30M |
|
$4.01M |
|
$2.31M |
|
$-1.70M |
|
$0.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-3.00M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-138.92% |
|
-138.92% |
|
-87.23% |
|
-138.92% |
|
$0.72 |
|
$-1.25 |
|
$-1.25 |
|